可开发性评估

Developability assessment that catches manufacturability risk while it is still cheap to fix. We profile aggregation, thermal and colloidal stability, charge heterogeneity, viscosity and chemical liabilities across your candidate panel, ranking molecules on the properties that decide CMC outcomes.

Watch our on-demand webinar:

Biological Macromolecules: Exploring Analytical Development and QC Case Studies in Antibody Developability and Biologics CMC

Presented by Dr. Jinghan Su, Assistant Director and Head of Developability, and Dr. Qian Sun, Director, Head of Analytical Development and Quality Control at ChemPartner.

  • Potential CDR hot spots analysis 
  • Biophysical characterization
  • Stability studies
  • High concentration possibility assessment
开启您的旅程
模态
治疗领域